HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viability of Q-wave infarcted myocardium with restored positive and persistent negative T waves after optimal revascularization compared with dobutamine stress echocardiography.

Abstract
To clarify the clinical difference in viability of myocardium with negative and positive T waves in Q-wave anterior or anteroseptal myocardial infarction, we performed low-dose dobutamine stress echocardiography in 17 patients with negative T waves and in 13 patients with positive T waves with optimal revascularization of infarct-related arteries in the chronic phase of infarction. At baseline the wall motion score (WMS) of the negative and positive T groups was 25.8 +/- 3.0 and 22.3 +/- 2.2 points (p <0.05), respectively. At peak stress WMS in each group was 27.2 +/- 4.2 and 19.8 +/- 2.4 points (p <0.0001), respectively. With dobutamine stress WMS in the positive T group was more decreased than that of the negative T group (p <0.0001). We conclude that the restored positive T waves in Q-wave myocardial infarction indicate a significantly greater amount of viable myocardium than the negative T waves, showing better regional wall motion improvement with low-dose dobutamine stress.
AuthorsS Watanabe, Y Kawamura, Y Watanabe, K Tanaka, K Tanaka, Y Takei, N Ejiri, K Shimada
JournalThe American journal of cardiology (Am J Cardiol) Vol. 85 Issue 1 Pg. 31-6 (Jan 01 2000) ISSN: 0002-9149 [Print] United States
PMID11078232 (Publication Type: Comparative Study, Journal Article, Validation Study)
Chemical References
  • Cardiotonic Agents
  • Dobutamine
  • Creatine Kinase
Topics
  • Aged
  • Cardiotonic Agents
  • Coronary Angiography
  • Creatine Kinase (blood)
  • Dobutamine
  • Echocardiography (methods)
  • Electrocardiography (methods)
  • Exercise Test (methods)
  • Female
  • Follow-Up Studies
  • Hemodynamics
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnosis, enzymology, physiopathology, therapy)
  • Myocardial Revascularization (methods)
  • Prognosis
  • Sensitivity and Specificity
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: